• Mutation; VGNC; VGNC:54284; CCND3; Simple; p.Ala66_Ser67del (c.194_199delGCGCCA); Zygosity=Homozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:42422; KIT; Unexplicit; Tandem duplication of a 48bp sequence; Zygosity=Unspecified (PubMed=10210327).
  
• Mutation; VGNC; VGNC:47719; TP53; Simple; p.Val162Ala (c.485T>C); Zygosity=Homozygous (PubMed=31175136).
  

PubMed=2431625; DOI=10.1152/ajpcell.1986.251.6.C935
Stephen C. Lazarus, Rebekah DeVinney, Laurence J. McCabe, Walter E. Finkbeiner, Darlene J. Elias, Warren M. Gold;
Isolated canine mastocytoma cells: propagation and characterization of two cell lines.
Am. J. Physiol. 251:C935-C944(1986)

PubMed=2121170; DOI=10.1165/ajrcmb/3.5.413
Rebekah DeVinney, Warren M. Gold;
Establishment of two dog mastocytoma cell lines in continuous culture.
Am. J. Respir. Cell Mol. Biol. 3:413-420(1990)

PubMed=1634619; DOI=10.1172/JCI115853; PMCID=PMC443060
Daniel W. Pennington, Alfredo R. Lopez, Paul S. Thomas, Caroline Peck, Warren M. Gold;
Dog mastocytoma cells produce transforming growth factor beta 1.
J. Clin. Invest. 90:35-41(1992)

PubMed=10210327; DOI=10.1016/S0301-472X(98)00075-7
Cheryl A. London, Stephen Joseph Galli, Toshifumi Yuuki, Zhi-Qing Hu, Stuart C. Helfand, Edwin N. Geissler;
Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit.
Exp. Hematol. 27:689-697(1999)

PubMed=19185923; DOI=10.1016/j.vetimm.2008.12.023
Richard Christopher Elders, Stephen J. Baines, Brian Catchpole;
Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Vet. Immunol. Immunopathol. 130:11-16(2009)

PubMed=25190452; DOI=10.1186/s12917-014-0184-9; PMCID=PMC4172958
Lisa Y. Pang, Sally Anne Argyle, Ayako Kamida, Katherine O'Neill Morrison, David John Argyle;
The long-acting COX-2 inhibitor mavacoxib (Trocoxil TM) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro.
BMC Vet. Res. 10:184.1-184.11(2014)

PubMed=27257868; DOI=10.1371/journal.pone.0156689; PMCID=PMC4892608
Junko Maeda, Coral Eva Froning, Colleen A. Brents, Barbara J. Rose, Douglas H. Thamm, Takamitsu A. Kato;
Intrinsic radiosensitivity and cellular characterization of 27 canine cancer cell lines.
PLoS ONE 11:e0156689.1-e0156689.18(2016)

PubMed=26842912; DOI=10.1111/vco.12197
Genevieve Hartley, Erica Ann Faulhaber, Alison Caldwell, Jonathan Coy, Jade N. Kurihara, Amanda Guth, Daniel P. Regan, Steven W. Dow;
Immune regulation of canine tumour and macrophage PD-L1 expression.
Vet. Comp. Oncol. 15:534-549(2017)

PubMed=27197945; DOI=10.1111/vco.12192; PMCID=PMC5656225
Jared S. Fowles, Deanna D. Dailey, Daniel L. Gustafson, Douglas H. Thamm, Dawn L. Duval;
The Flint Animal Cancer Center (FACC) canine tumour cell line panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.
Vet. Comp. Oncol. 15:481-492(2017)

PubMed=31175136; DOI=10.1158/1535-7163.MCT-18-1346; PMCID=PMC6679748
Sunetra Das, Rupa Idate, Kathryn E. Cronise, Daniel L. Gustafson, Dawn L. Duval;
Identifying candidate druggable targets in canine cancer cell lines using whole-exome sequencing.
Mol. Cancer Ther. 18:1460-1471(2019)